David A. Siegel Humacyte, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Humacyte, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 264,300 shares of HUMA stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
264,300Holding current value
$1.41 Million% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
130Shares Held
30.8MCall Options Held
323KPut Options Held
582K-
Black Rock Inc. New York, NY7.14MShares$38.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$25.3 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$15.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$9.94 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.6MShares$8.54 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $550M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...